Innovation, Quality Enhancement, and Transformation – Focusfreda Holds its Work Conference for the First Half of 2026
On July 24, Focusfreda held its work conference for the first half of 2026. The conference aimed to thoroughly study and grasp the spirit of the Lushang Group and Lushang Freda work conferences for the first half of 2026, conduct a comprehensive review of the company's operating performance during the first half of the year, conduct an in-depth examination of existing gaps, shortcomings, and prominent issues, and systematically deploy key tasks for the second half of the year. The conference mobilized all employees and management personnel to further align their thinking and strengthen their confidence, leveraging determination to overcome challenges and improve quality, as well as a pragmatic and action-oriented approach, to make every effort toward achieving the annual targets and objectives. Zheng Deqiang, Member of the Party Committee of Freda, Deputy General Manager, and Chairman of Focusfreda, attended the conference and delivered a concluding speech.

The meeting commenced with CFO Zhang Yongming conveying the key directives of the Lushang Group and Lushang Freda work conference for the first half of 2026. The meeting emphasized that all employees and officials must align their actions precisely with the Group's strategic deployment, stay closely focused on the "Two-Year Quality Improvement" objective, maintain a clear direction, intensify efforts, and effectively translate the spirit of the Group's conference into concrete actions to drive the company's high-quality development.
Subsequently, the company's leadership team and their respective deputies reported on the semi-annual work summary, existing issues, and work plans for the following departments: R&D, Quality Control, Production Engineering, Supply Chain, Safety and Environmental Protection, Administration, Finance, and Marketing. Each presenter conducted a thorough self-assessment and self-correction process against the annual targets, performed an in-depth analysis of the root causes, and proposed targeted rectification measures.

In his concluding speech, Zheng Deqiang fully affirmed the outcomes of the meeting. He pointed out that the reports presented by the respective leaders in charge were comprehensive and detailed, the analysis of identified issues was thorough and insightful, and the plans for the second half of the year are scientific and well-rounded. During the first half of the year, the company achieved phased milestones in areas such as profitability, registration, customer development, and quality improvement and efficiency enhancement; over the past four years, the company's performance has maintained a consistently positive trajectory. These achievements would not have been possible without the unity and collaboration of the leadership team and the hard work of all employees.

Regarding the key tasks for the second half of the year, Zheng Deqiang emphasized that the focus for the latter half of the year should be on innovation, quality improvement, and transformation, and he outlined seven requirements:
First, we must closely monitor our revenue targets and wage a decisive battle to achieve the annual objectives. All departments shall review their annual key tasks item by item to identify and fill any gaps, reinforce job responsibilities, and advance implementation through a closed-loop process; furthermore, they shall steadily implement all improvement measures in accordance with the plan for the second half of the year, ensuring the successful completion of all set annual goals.
The second point is to closely monitor industry trends and seize market initiative. It is essential to keep a close watch on industry developments, conduct in-depth analyses of the strategies employed by leading enterprises, develop targeted plans, and thereby gain the upper hand in highly competitive environments.
The third priority is to deepen marketing transformation and accelerate the translation of R&D achievements into products and sales revenue; this involves driving the shift toward technology-driven marketing, converting R&D scientific and technological achievements into tangible products and sales revenue, identifying bottlenecks in existing processes, overcoming key barriers in the commercialization of scientific and technological achievements, and further facilitating the implementation of R&D outcomes into market-ready products.
Fourth, we will align ourselves with industry benchmarks to continuously enhance quality and efficiency. By benchmarking against leading enterprises in key areas such as registration and production costs, we will identify gaps and address weaknesses, thereby comprehensively improving operational efficiency and cost control capabilities, and driving the company toward a deeper transition toward a "quality-and-efficiency-oriented" development model.
The fifth measure is to strengthen talent support and consolidate the foundation for development. We must provide solid talent support for the company's high-quality development, ensure that qualified personnel are assigned to key positions and critical areas, and leverage our talent advantages to empower business growth.
Sixth, accelerate project development and expand growth opportunities: conduct in-depth research on the future development direction of terminal products to scientifically formulate the next phase of plans; advance the construction of pilot-scale platforms for synthetic biology and green intelligent manufacturing to seize the development opportunities presented by the new frontier of biomanufacturing.
Seventh, expand AI applications and accelerate digital-intelligent empowerment; further advance the digitalization and intelligent transformation of production processes and enhance their digital-intelligent empowerment capabilities; establish a digital-intelligent transformation team to drive the transition toward core competency upgrades through digital-intelligent transformation.
The meeting called upon all cadres and staff to maintain firm confidence, face challenges head-on, address existing weaknesses, strengthen underdeveloped areas, and ensure effective implementation, making every effort to win the critical operational battle in the second half of the year.
Members of the company's leadership team and their respective supervising leaders attended the meeting.
RECOMMENDED READING
CONTACT US
Tel:+86-0537-3195566
E-mail:sales@focuschem.com
Add:Economic Development Zone, High-speed Railway New District, Qufu City, Jining City, Shandong Province, China
Copyright © 2022 Shandong Focusfreda Biotech Co., Ltd. 鲁ICP备2021008509号-2 Powerby : 300.cn jinan SEO